DES    Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions Catheter Cardiovasc Interv (2009 H. M. Yang, S. J. Tahk, S. I. Woo, H. S. Lim, B. J. Choi, S. Y. Choi, M. H. Yoon, J. S. Park, M. Zheng, G. S. Hwang, S. J. Kang and J. H. Shin Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry) Am J Cardiol (2008) 101; 1716-22 B. P. Yan, S. J. Duffy, D. J. Clark, J. Lefkovits, R. Warren, R. Gurvitch, R. Lew, M. Sebastian, A. Brennan, N. Andrianopoulos, C. M. Reid and A. E. Ajani Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk Catheter Cardiovasc Interv (2008) 71; 533-8 F. O. Wood, E. K. Saylors, J. E. Schneider, R. L. Jobe and J. T. Mann, 3rd Drug-eluting versus bare-metal stents in acute myocardial infarction N Engl J Med (2009) 360; 300; author reply 01-2 B. Y. Wong Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet (2008) 372; 1163-73 S. Windecker, P. W. Serruys, S. Wandel, P. Buszman, S. Trznadel, A. Linke, K. Lenk, T. Ischinger, V. Klauss, F. Eberli, R. Corti, W. Wijns, M. C. Morice, C. di Mario, S. Davies, R. J. van Geuns, P. Eerdmans, G. A. van Es, B. Meier and P. Juni Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 594-8 C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 594-8 C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol (2008) 52; 1134-40 P. Wenaweser, J. Daemen, M. Zwahlen, R. van Domburg, P. Juni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, E. Boersma, N. Kukreja, B. Meier, P. W. Serruys and S. Windecker Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual Catheter Cardiovasc Interv (2008) 71; 636-43 F. W. Wang, B. F. Uretsky, J. L. Freeman, D. Zhang, S. H. Giordano and J. S. Goodwin Drug-eluting stents: is new necessarily better Lancet (2008) 372; 1126-8 R. Waksman Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort Catheter Cardiovasc Interv (2008) 71; 764-9 P. J. Vlaar, C. S. Rihal, M. Singh, R. Lennon, H. H. Ting, J. F. Bresnahan and D. R. Holmes, Jr. Drug-eluting stents in octogenarians: early and intermediate outcome Am Heart J (2008) 155; 680-6 . J. Vlaar, R. J. Lennon, C. S. Rihal, M. Singh, H. H. Ting, J. F. Bresnahan and D. R. Holmes, Jr Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry) Am J Cardiol (2008) 101; 947-52 L. Vignali, F. Saia, A. Manari, A. Santarelli, A. Rubboli, E. Varani, G. Piovaccari, A. Menozzi, G. Percoco, A. Benassi, G. Rusticali, P. Marzaroli, P. Guastaroba, R. Grilli, A. Maresta and A. Marzocchi 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study J Am Coll Cardiol (2009) 53; 1031-9 S. Verheye, P. Agostoni, C. L. Dubois, J. Dens, J. Ormiston, S. Worthley, B. Trauthen, T. Hasegawa, B. K. Koo, P. J. Fitzgerald, R. Mehran and A. J. Lansky Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study J Am Coll Cardiol (2008) 51; 618-26 B. L. van der Hoeven, S. S. Liem, J. W. Jukema, N. Suraphakdee, H. Putter, J. Dijkstra, D. E. Atsma, M. Bootsma, K. Zeppenfeld, P. V. Oemrawsingh, E. E. van der Wall and M. J. Schalij Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA (2008) 299; 1788-99 M. Valgimigli, G. Campo, G. Percoco, L. Bolognese, C. Vassanelli, S. Colangelo, N. de Cesare, A. E. Rodriguez, M. Ferrario, R. Moreno, T. Piva, I. Sheiban, G. Pasquetto, F. Prati, M. S. Nazzaro, G. Parrinello and R. Ferrari Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion Eur Heart J (2008) 29; 2336-42 R. Valenti, A. Migliorini, U. Signorini, R. Vergara, G. Parodi, N. Carrabba, G. Cerisano and D. Antoniucci Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator Catheter Cardiovasc Interv (2009) 73; 475-80 M. Utunomiya, O. Katoh and S. Nakamura Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents J Am Coll Cardiol (2008) 51; 1925-34 . Trenk, W. Hochholzer, M. F. Fromm, L. E. Chialda, A. Pahl, C. M. Valina, C. Stratz, P. Schmiebusch, H. P. Bestehorn, H. J. Buttner and F. J. Neumann An evidence-based approach to the use of rotational and directional coronary atherectomy in the era of drug-eluting stents: when does it make sense? Catheter Cardiovasc Interv (2008) 72; 650-62 T. Tran, M. Brown and J. Lasala Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform Catheter Cardiovasc Interv (2009) 73; 597-604 C. A. Thompson, B. Huibregtse, B. Poff and G. J. Wilson Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes Am J Cardiol (2009) 103; 187-93 C. Tamburino, M. E. Di Salvo, D. Capodanno, T. Palmerini, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone and S. De Servi Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry Eur Heart J (2009) C. Tamburino, M. E. Di Salvo, D. Capodanno, A. Marzocchi, I. Sheiban, M. Margheri, A. Maresta, F. Barlocco, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, A. Patti and S. De Servi Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry Catheter Cardiovasc Interv (2009) 73; 243-8 C. Tamburino, M. E. Di Salvo, D. Capodanno, P. Capranzano, R. Parisi, F. Mirabella, F. Scardaci, G. Ussia, A. R. Galassi, D. Fiscella, R. Mehran and G. Dangas Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents Catheter Cardiovasc Interv (2008) 72; 448-56 C. Tamburino, D. J. Angiolillo, P. Capranzano, K. Dimopoulos, A. La Manna, R. Barbagallo, F. Tagliareni, S. Mangiafico, L. A. Guzman, A. R. Galassi and T. A. Bass Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease Catheter Cardiovasc Interv (2009) 73; 291-8 C. Tamburino, D. J. Angiolillo, P. Capranzano, M. Di Salvo, G. Ussia, A. La Manna, L. A. Guzman, A. R. Galassi and T. A. Bass Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist J Am Coll Cardiol (2008) 51; 968-9 M. Takano, M. Yamamoto, S. Inami, D. Murakami, K. Seimiya, T. Ohba, Y. Seino and K. Mizuno Does prior PCI increase the risk of subsequent CABG? Eur Heart J (2008) 29; 573-5 D. P. Taggart The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns J Am Coll Cardiol (2008) 52; 1680-1; author reply 81 D. Taggart Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA (2008) 299; 1903-13 G. W. Stone, M. Midei, W. Newman, M. Sanz, J. B. Hermiller, J. Williams, N. Farhat, K. W. Mahaffey, D. E. Cutlip, P. J. Fitzgerald, P. Sood, X. Su and A. J. Lansky Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial Circulation (2009) 119; 680-6 . W. Stone, M. Midei, W. Newman, M. Sanz, J. B. Hermiller, J. Williams, N. Farhat, R. Caputo, N. Xenopoulos, R. Applegate, P. Gordon, R. M. White, K. Sudhir, D. E. Cutlip and J. L. Petersen Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol (2009) 103; 491-5 D. H. Steinberg, M. A. Gaglia, Jr., T. L. Pinto Slottow, P. Roy, L. Bonello, A. De Labriolle, G. Lemesle, R. Torguson, K. Kineshige, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J (2009) 30; 321-9 P. G. Steg, K. A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang and J. M. Gore Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention Am J Cardiol (2008) 102; 311-5 E. Solinas, G. Dangas, A. J. Kirtane, A. J. Lansky, T. Franklin-Bond, P. Boland, G. Syros, Y. H. Kim, A. Gupta, G. Mintz, M. Fahy, M. Collins, S. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and R. Mehran Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol (2009) 53; 849-56 D. Sibbing, S. Braun, T. Morath, J. Mehilli, W. Vogt, A. Schomig, A. Kastrati and N. von Beckerath Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality J Am Coll Cardiol (2008) 52; 1041-8 M. H. Shishehbor, S. S. Goel, S. R. Kapadia, D. L. Bhatt, P. Kelly, R. E. Raymond, J. M. Galla, S. J. Brener, P. L. Whitlow and S. G. Ellis Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents Am Heart J (2008) 155; 1075-80 M. H. Shishehbor, R. Amini, R. E. Raymond, A. A. Bavry, S. J. Brener, S. R. Kapadia, P. L. Whitlow, S. G. Ellis and D. L. Bhatt Stents versus coronary-artery bypass grafting for left main coronary artery disease N Engl J Med (2008) 358; 1781-92 K. B. Seung, D. W. Park, Y. H. Kim, S. W. Lee, C. W. Lee, M. K. Hong, S. W. Park, S. C. Yun, H. C. Gwon, M. H. Jeong, Y. Jang, H. S. Kim, P. J. Kim, I. W. Seong, H. S. Park, T. Ahn, I. H. Chae, S. J. Tahk, W. S. Chung and S. J. Park A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet (2009) 373; 897-910 P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hebert, S. Veldhof, M. Webster, L. Thuesen and D. Dudek Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med (2009) 360; 961-72 P. W. Serruys, M. C. Morice, A. P. Kappetein, A. Colombo, D. R. Holmes, M. J. Mack, E. Stahle, T. E. Feldman, M. van den Brand, E. J. Bass, N. Van Dyck, K. Leadley, K. D. Dawkins and F. W. Mohr A comparison of the mechanical performance characteristics of seven drug-eluting stent systems Catheter Cardiovasc Interv (2009) 73; 350-60 W. Schmidt, P. Lanzer, P. Behrens, L. D. Topoleski and K. P. Schmitz Stenting of spontaneous intramural coronary haematoma: long-term consequences Eur Heart J (2008) 29; 1593 A. Sanchez-Recalde, R. Moreno and S. Jimenez-Valero Which patients receiving warfarin can be treated safely with a drug-eluting stent Heart (2008) 94; 275-7 A. D. Ryding and A. P. Banning Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program Circulation (2009) 119; 952-61 J. Ryan, W. Linde-Zwirble, L. Engelhart, L. Cooper and D. J. Cohen Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions Catheter Cardiovasc Interv (2008) 71; 333-9 J. Ruef, H. Storger, F. Schwarz and J. Haase The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents Eur Heart J (2008) 29; 1851-7 P. Roy, D. H. Steinberg, S. J. Sushinsky, T. Okabe, T. L. Pinto Slottow, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, N. J. Weissman, J. Lindsay and R. Waksman Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention Am J Cardiol (2008) 101; 293-9 P. Roy, A. N. Buch, A. Javaid, T. Okabe, V. Raya, T. L. Pinto Slottow, D. H. Steinberg, K. Smith, Z. Xue, N. Gevorkian, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, J. Lindsay and R. Waksman Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry) Am J Cardiol (2008) 102; 292-7 P. Roy, L. Bonello, A. de Labriolle, T. Okabe, T. L. Pinto Slottow, D. H. Steinberg, R. Torguson, K. Smith, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard and R. Waksman Drug-eluting versus bare-metal stents in acute myocardial infarction N Engl J Med (2009) 360; 301; author reply 01-2 K. J. Rothman Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study Circulation (2008) 117; 605-13 G. A. Rosito, J. M. Massaro, U. Hoffmann, F. L. Ruberg, A. A. Mahabadi, R. S. Vasan, C. J. O'Donnell and C. S. Fox Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up Catheter Cardiovasc Interv (2008) 72; 112-5 O. R. Rosales, S. Mathewkutty and C. Gnaim Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty Catheter Cardiovasc Interv (2008) 71; 759-63 M. Romano, F. Buffoli, L. Tomasi, L. Corrado, M. R. Ferrari and R. Zanini Commentary on drug-eluting stents: NICE technology appraisal guidance Heart (2008) 94; 1650-2 J. Richardson, A. Stevens, D. Barnett and C. Longson Outcomes in the era of bare-metal stents vs the era of drug-eluting stents JAMA (2009) 301; 33-4; author reply 34 J. A. Rassen and S. Schneeweiss Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Catheter Cardiovasc Interv (2008) 71; 886-93 R. K. Ramana, A. Ronan, K. Cohoon, D. Homan, J. Sutherland, L. Steen, J. Liu, H. Loeb and B. E. Lewis Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era Am J Cardiol (2008) 101; 63-8 T. Pucelikova, R. Mehran, A. J. Kirtane, Y. H. Kim, M. Fahy, G. Weisz, A. J. Lansky, I. Moussa, W. A. Gray, M. B. Collins, S. K. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and G. Dangas Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J (2008) 29; 992-1000 M. J. Price, S. Endemann, R. R. Gollapudi, R. Valencia, C. T. Stinis, J. P. Levisay, A. Ernst, N. S. Sawhney, R. A. Schatz and P. S. Teirstein Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials J Am Coll Cardiol (2008) 51; 23-32 S. J. Pocock, A. J. Lansky, R. Mehran, J. J. Popma, M. P. Fahy, Y. Na, G. Dangas, J. W. Moses, T. Pucelikova, D. E. Kandzari, S. G. Ellis, M. B. Leon and G. W. Stone Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry) Am J Cardiol (2008) 101; 953-9 D. Planer, R. Beyar, Y. Almagor, S. Banai, V. Guetta, H. Miller, R. Kornowski, S. Brandes, R. Krakover, M. Solomon and C. Lotan Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials Catheter Cardiovasc Interv (2009) F. Piscione, R. Piccolo, S. Cassese, G. Galasso and M. Chiariello Commentary on drug-eluting stents: to use or not to use--that is the question! Heart (2008) 94; 1648-50 M. E. Pfisterer Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET Eur Heart J (2009) 30; 16-24 M. Pfisterer, H. P. Brunner-La Rocca, P. Rickenbacher, P. Hunziker, C. Mueller, F. Nietlispach, G. Leibundgut, F. Bader and C. Kaiser The balance of risks and benefits of drug-eluting versus bare-metal stents J Am Coll Cardiol (2008) 51; 972; author reply 72-3 M. Pfisterer, H. P. Brunner-La Rocca and C. Kaiser Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design Am Heart J (2008) 155; 609-14 M. Pfisterer, O. Bertel, P. O. Bonetti, H. P. Brunner-La Rocca, F. R. Eberli, P. Erne, S. Galatius, B. Hornig, W. Kiowski, O. Pachinger, G. Pedrazzini, H. Rickli, S. De Servi and C. Kaiser Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus Am J Cardiol (2008) 102; 1328-34 G. Patti, A. Nusca and G. Di Sciascio Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study) Am J Cardiol (2009) 103; 181-6 M. R. Patel, M. E. Pfisterer, A. Betriu, P. Widmisky, D. R. Holmes, Jr., W. W. O'Neill, A. Stebbins, F. Van de Werf, P. W. Armstrong and C. B. Granger Next-generation drug-eluting stents: a spirited step forward or more of the same JAMA (2008) 299; 1952-3 M. R. Patel and D. R. Holmes, Jr. Current status of percutaneous coronary intervention with drug-eluting stents in Asia Circulation (2008) 118; 2730-7 S. J. Park and Y. H. Kim Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease Circulation (2008) 117; 2079-86 D. W. Park, S. C. Yun, S. W. Lee, Y. H. Kim, C. W. Lee, M. K. Hong, J. J. Kim, S. J. Choo, H. Song, C. H. Chung, J. W. Lee, S. W. Park and S. J. Park Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology Am J Cardiol (2008) 102; 1463-8 T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. Bartorelli, C. Briguori, L. Vignali, F. Di Pede, A. Ramondo, L. Inglese, M. De Carlo, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, D. Sangiorgi and S. De Servi Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry Circulation (2008) 117; 923-30 P. Ortolani, M. Balducelli, P. Marzaroli, G. Piovaccari, A. Menozzi, V. Guiducci, P. Sangiorgio, F. Tarantino, G. Geraci, F. Castriota, S. Tondi, F. Saia, R. M. Cooke, P. Guastaroba, R. Grilli, A. Marzocchi and A. Maresta Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts Am J Cardiol (2008) 102; 530-4 T. Okabe, J. Lindsay, A. N. Buch, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman and R. Waksman EVENT registry Catheter Cardiovasc Interv (2008) V. Novack, D. Tsyvine, D. J. Cohen, M. Pencina, J. Dubin, H. Dehghani, N. S. Kleiman and D. E. Cutlip Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents Catheter Cardiovasc Interv (2008) 71; 896-906 E. Nikolsky, D. R. Holmes, R. Mehran, G. Dangas, E. Schampaert, M. C. Morice, J. Schofer, J. E. Sousa, M. Fahy, Y. Na, D. J. Donohoe, J. W. Moses and M. B. Leon Biodegradable coating for drug-eluting stents--more than a facelift? Eur Heart J (2008) 29; 1930-1 K. O. Niemela Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2643; author reply 43-4 A. C. Ng and L. Kritharides Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation (2008) 118; 1138-45 G. Nakazawa, A. V. Finn, M. Joner, E. Ladich, R. Kutys, E. K. Mont, H. K. Gold, A. P. Burke, F. D. Kolodgie and R. Virmani Drug-eluting stent implantation may not affect vasomotor function in early phase J Am Coll Cardiol (2008) 51; 1124-5; author reply 25 G. Nakazawa, Q. Cheng, X. Xu, A. V. Finn, F. D. Kolodgie and R. Virmani Effectiveness of drug-eluting stents in real-world patients JAMA (2008) 299; 454-5 D. Mukherjee and D. J. Moliterno Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel Eur Heart J (2008) 29; 1595-6 D. Mukherjee NICE, drug-eluting stents and the limits of trial data Heart (2009) 95; 505-6; author reply 06 R. Mohindra Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III Am Heart J (2008) 155; 108-13 A. Miyazawa, J. Ako, Y. Hongo, S. H. Hur, I. Tsujino, B. K. Courtney, A. H. Hassan, D. E. Kandzari, Y. Honda and P. J. Fitzgerald Correlates of late and very late thrombosis of drug eluting stents Am Heart J (2008) 156; 141-7 G. J. Mishkel, A. L. Moore, S. Markwell and M. E. Shelton Drug-eluting stents: a critique Heart (2008) 94; 145-52 N. Melikian and W. Wijns Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry J Am Coll Cardiol (2008) 51; 2212-9 E. Meliga, H. M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A. O. Maree, S. Cook, L. Reardon, C. Moretti, S. De Servi, I. F. Palacios, S. Windecker, A. Colombo, R. van Domburg, I. Sheiban and P. W. Serruys Optimizing trial design: sequential, adaptive, and enrichment strategies Circulation (2009) 119; 597-605 C. Mehta, P. Gao, D. L. Bhatt, R. A. Harrington, S. Skerjanec and J. H. Ware Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis Eur Heart J (2008) 29; 1975-82 J. Mehilli, R. A. Byrne, A. Wieczorek, R. Iijima, S. Schulz, O. Bruskina, J. Pache, R. Wessely, A. Schomig and A. Kastrati One-year outcomes from the TAXUS express stent versus cypher stent Am J Cardiol (2009) 103; 930-6 M. Mayor, A. Z. Malik, R. J. Minor, Jr., M. C. Deshpande, W. E. Strauss, T. H. Maloney, D. S. Baim, W. O'Neill and D. E. Kandzari Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Circulation (2008) 118; 1817-27 L. Mauri, T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, Z. Zhou, F. S. Resnic and S. L. Normand Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med (2008) 359; 1330-42 L. Mauri, T. S. Silbaugh, P. Garg, R. E. Wolf, K. Zelevinsky, A. Lovett, M. R. Varma, Z. Zhou and S. L. Normand A new 0.010-inch guidewire and compatible balloon catheter system: the IKATEN registry Catheter Cardiovasc Interv (2009) 73; 605-10 T. Matsukage, F. Yoshimachi, M. Masutani, T. Katsuki, S. Saito, A. Takahashi, K. Iida, Y. Katahira, I. Michishita, K. Tanabe, Y. Kan and Y. Ikari A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med (2008) 358; 342-52 O. C. Marroquin, F. Selzer, S. R. Mulukutla, D. O. Williams, H. A. Vlachos, R. L. Wilensky, J. F. Tanguay, E. M. Holper, J. D. Abbott, J. S. Lee, C. Smith, W. D. Anderson, S. F. Kelsey and K. E. Kip Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study) Am J Cardiol (2008) 101; 1560-6 A. Maresta, E. Varani, M. Balducelli, F. Varbella, C. Lettieri, L. Uguccioni, P. Sangiorgio and G. B. Zoccai Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents JAMA (2008) 299; 2868-76 D. J. Malenka, A. V. Kaplan, F. L. Lucas, S. M. Sharp and J. S. Skinner Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis J Am Coll Cardiol (2008) 51; 2385-95 E. Mahmud, G. Bromberg-Marin, V. Palakodeti, L. Ang, D. Creanga and A. N. Demaria Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus Am J Cardiol (2008) 102; 165-72 M. Maeng, L. O. Jensen, A. Kaltoft, H. H. Hansen, M. Bottcher, J. F. Lassen, P. Thayssen, L. R. Krusell, K. Rasmussen, L. Pedersen, H. T. Sorensen, S. P. Johnsen and L. Thuesen Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol (2009) 103; 345-9 M. Maeng, L. O. Jensen, A. M. Galloe, P. Thayssen, E. H. Christiansen, K. N. Hansen, S. Helqvist, H. E. Botker, J. F. Lassen and L. Thuesen An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents Am J Cardiol (2009) 103; 501-6 . Liu, A. Maehara, G. S. Mintz, N. J. Weissman, A. Yu, H. Wang, L. Mandinov, J. J. Popma, S. G. Ellis, E. Grube, K. D. Dawkins and G. W. Stone Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease. Three-Year Follow-Up Results From a Single Institution Circulation (2009) Y. Li, Z. Zheng, B. Xu, S. Zhang, W. Li, R. Gao and S. Hu Early days of an ingenious aspirin and sirolimus-eluting stent Catheter Cardiovasc Interv (2008) 72; 195 P. A. Lemos Three aneurysms developed in three different drug-eluting stents Eur Heart J (2009) Y. S. Lee, K. S. Kim and S. G. Chang CABG vs. stenting--clinical implications of the SYNTAX trial N Engl J Med (2009) 360; e10 T. H. Lee, L. D. Hillis and E. G. Nabel A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial J Am Coll Cardiol (2009) 53; 812-3 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, K. S. Rhee, J. K. Chae, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, J. O. Jeong, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun, H. S. Kim and S. J. Park A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol (2008) 52; 727-33 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, K. S. Rhee, J. K. Chae, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, J. O. Jeong, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun, H. S. Kim and S. J. Park Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) Am Coll Cardiol (2008) 51; 1181-7 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, H. S. Kim, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun and S. J. Park Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 526-30 M. S. Lee, R. Zimmer, A. Pessegueiro, D. Jurewitz and J. Tobis Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction Catheter Cardiovasc Interv (2009) 73; 15-21 M. S. Lee, D. Sillano, A. Latib, A. Chieffo, G. B. Zoccai, R. Bhatia, I. Sheiban, A. Colombo and J. Tobis Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents Catheter Cardiovasc Interv (2008) 72; 909-14 M. S. Lee, D. Jurewitz, R. Zimmer, A. Pessegueiro, R. Bhatia, J. Currier, L. Yeatman and J. M. Tobis Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience Catheter Cardiovasc Interv (2008) 71; 306-11 . S. Lee, K. J. Chun and J. M. Tobis Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial Catheter Cardiovasc Interv (2008) 72; 25-32 J. H. Lee, H. S. Kim, S. W. Lee, J. H. Park, S. W. Choi, J. O. Jeong, Y. Cho, N. Lee, K. S. Rhee, J. K. Ko and I. W. Seong Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations Am Heart J (2008) 156; 745-50 A. Latib, J. Cosgrave, C. Godino, A. Qasim, S. J. Corbett, D. Tavano, N. Morici, N. Cristell, A. Chieffo, M. Carlino, M. Montorfano, F. Airoldi and A. Colombo Bifurcation stenting: current strategies and new devices Heart (2009) 95; 495-504 A. Latib, A. Colombo and G. M. Sangiorgi Coronary revascularization in context N Engl J Med (2009) 360; 1024-6 R. A. Lange and L. D. Hillis Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) Heart (2009) N. Kukreja, P. W. Serruys, B. de Bruyne, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, C. Hamm, D. Goedhart, N. Macours and H. P. Stoll Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients Am J Cardiol (2009) 103; 203-11 N. Kukreja, Y. Onuma, H. M. Garcia-Garcia, J. Daemen, R. van Domburg and P. W. Serruys A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study J Am Coll Cardiol (2008) 51; 1543-52 M. W. Krucoff, D. J. Kereiakes, J. L. Petersen, R. Mehran, V. Hasselblad, A. J. Lansky, P. J. Fitzgerald, J. Garg, M. A. Turco, C. A. Simonton, 3rd, S. Verheye, C. L. Dubois, R. Gammon, W. B. Batchelor, C. D. O'Shaughnessy, J. B. Hermiller, Jr., J. Schofer, M. Buchbinder and W. Wijns Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve Eur Heart J (2008) 29; 726-32 B. K. Koo, K. W. Park, H. J. Kang, Y. S. Cho, W. Y. Chung, T. J. Youn, I. H. Chae, D. J. Choi, S. J. Tahk, B. H. Oh, Y. B. Park and H. S. Kim Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation (2009) 119; 987-95 T. Kimura, T. Morimoto, Y. Nakagawa, T. Tamura, K. Kadota, H. Yasumoto, H. Nishikawa, Y. Hiasa, T. Muramatsu, T. Meguro, N. Inoue, H. Honda, Y. Hayashi, S. Miyazaki, S. Oshima, T. Honda, N. Shiode, M. Namura, T. Sone, M. Nobuyoshi, T. Kita and K. Mitsudo Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus Am J Cardiol (2008) 101; 1263-8 M. Kimura, G. S. Mintz, N. J. Weissman, K. D. Dawkins, E. Grube, S. G. Ellis, L. A. Cannon, Z. Masud, L. Mandinov, D. Baim and G. W. Stone The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation Catheter Cardiovasc Interv (2008) Y. S. Kim, B. K. Koo, J. B. Seo, K. W. Park, J. W. Suh, H. Y. Lee, J. S. Park, H. J. Kang, Y. S. Cho, W. Y. Chung, I. H. Chae, D. J. Choi, H. S. Kim, B. H. Oh and Y. B. Park The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents Am J Cardiol (2008) 102; 1182-6 S. W. Kim, G. S. Mintz, Y. J. Hong, R. Pakala, K. S. Park, A. D. Pichard, L. F. Satler, K. M. Kent, W. O. Suddath, R. Waksman and N. J. Weissman Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]) Am J Cardiol (2008) 102; 304-10 J. S. Kim, J. Y. Moon, Y. G. Ko, D. Choi, Y. Jang, W. C. Kang, T. Ahn, B. K. Kim, S. J. Oh, D. W. Jeon and J. Y. Yang Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry Catheter Cardiovasc Interv (2008) 72; 601-7 J. S. Kim, B. H. Lee, Y. G. Ko, D. Choi, Y. Jang, P. K. Min, Y. W. Yoon, B. K. Hong, H. M. Kwon, M. S. Ahn, S. H. Lee, J. H. Yoon, B. K. Lee, B. O. Kim, B. K. Kim, S. J. Oh, D. W. Jeon, J. Y. Yang, J. R. Cho, J. H. Jung and S. K. Ryu Drug-eluting versus bare-metal stents in acute myocardial infarction N Engl J Med (2009) 360; 300-1; author reply 01-2 D. H. Kim Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II) Am J Cardiol (2008) 101; 1550-9 A. A. Khattab, J. Daemen, G. Richardt, P. Rioux, F. W. Amann, R. Levy, I. G. Horvath, R. C. Teles, F. Ordoubadi, M. Pieters, K. Wittebols, H. P. Stoll and P. W. Serruys Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach Am Heart J (2008) 155; 624-9, 29 e1-2 D. M. Kent and T. A. Trikalinos Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial Circulation (2008) 118; 1155-62 H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Klovgaard, A. Kaltoft, B. Andersen, H. Thuesen, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, E. Jorgensen, H. H. Hansen, E. H. Christiansen, J. Ravkilde, L. Kober, K. F. Kofoed, C. J. Terkelsen and J. F. Lassen Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial J Am Coll Cardiol (2008) 51; 2011-6 H. Kelbaek, L. Klovgaard, S. Helqvist, J. F. Lassen, L. R. Krusell, T. Engstrom, H. E. Botker, E. Jorgensen, K. Saunamaki, S. Aljabbari, P. Thayssen, A. Galloe, G. V. Jensen and L. Thuesen Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion Catheter Cardiovasc Interv (2009) 73; 205-11 T. Kawasaki, H. Koga, T. Serikawa, Y. Orita, S. Ikeda, T. Mito, Y. Gotou, Y. Shintani, A. Tanaka, H. Tanaka, T. Fukuyama and N. Koga Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction Heart (2008) 94; 604-9 H. J. Kang, Y. S. Kim, B. K. Koo, K. W. Park, H. Y. Lee, D. W. Sohn, B. H. Oh, Y. B. Park and H. S. Kim 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol (2009) 53; 658-64 A. Kaltoft, L. O. Jensen, M. Maeng, H. H. Tilsted, P. Thayssen, M. Bottcher, J. F. Lassen, L. R. Krusell, K. Rasmussen, K. N. Hansen, L. Pedersen, S. P. Johnsen, H. T. Sorensen and L. Thuesen Paclitaxel-eluting stent long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study Am J Cardiol (2009) 103; 199-202 M. H. Jim, H. H. Ho, R. L. Ko, K. H. Yiu, C. W. Siu, C. P. Lau and W. H. Chow Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry Circulation (2008) 118; 632-8 A. Jeremias, N. S. Kleiman, D. Nassif, W. H. Hsieh, M. Pencina, K. Maresh, M. Parikh, D. E. Cutlip, R. Waksman, S. Goldberg, P. B. Berger and D. J. Cohen Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial Eur Heart J (2008) 29; 2733-41 L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen and L. Thuesen Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus Am J Cardiol (2008) 102; 19-26 L. O. Jensen, M. Maeng, G. S. Mintz, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, H. S. Hansen, E. Joergensen, J. F. Lassen, L. Thuesen and P. Thayssen Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J (2009) 157; 599-605 S. James, A. Akerblom, C. P. Cannon, H. Emanuelsson, S. Husted, H. Katus, A. Skene, P. G. Steg, R. F. Storey, R. Harrington, R. Becker and L. Wallentin Late target lesion revascularization after implantation of sirolimus-eluting stent Catheter Cardiovasc Interv (2008) 71; 299-303 M. K. Hong, G. S. Mintz, C. W. Lee, D. W. Park, S. W. Lee, Y. H. Kim, I. H. Jung, S. H. Kim, S. S. Cheong, J. J. Kim, S. W. Park and S. J. Park Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J (2009) A. K. Hassan, S. C. Bergheanu, T. Stijnen, B. L. van der Hoeven, J. D. Snoep, J. W. Plevier, M. J. Schalij and J. W. Jukema Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2642-3; author reply 43-4 K. J. Harjai Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease N Engl J Med (2008) 358; 331-41 E. L. Hannan, C. Wu, G. Walford, A. T. Culliford, J. P. Gold, C. R. Smith, R. S. Higgins, R. E. Carlson and R. H. Jones Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents Circulation (2008) 117; 2071-8 E. L. Hannan, M. Racz, D. R. Holmes, G. Walford, S. Sharma, S. Katz, R. H. Jones and S. B. King, 3rd Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease Am J Cardiol (2009) 103; 194-8 Y. Han, S. Wang, Q. Jing, Y. Li, H. Liu, Y. Ma, Z. Wang, D. Wang, B. Luan, G. Wang and T. Chen Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents Catheter Cardiovasc Interv (2008) 72; 177-83 Y. Han, Q. Jing, X. Chen, S. Wang, Y. Ma, H. Liu, B. Luan, G. Wang, Y. Li, Z. Wang, D. Wang, B. Xu and R. Gao Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion J Am Coll Cardiol (2008) 51; 2123-9 M. I. Hamilos, M. Ostojic, B. Beleslin, D. Sagic, L. Mangovski, S. Stojkovic, M. Nedeljkovic, D. Orlic, B. Milosavljevic, D. Topic, N. Karanovic and W. Wijns The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis Heart (2008) 94; 1162-5 S. Habara, K. Mitsudo, T. Goto, K. Kadota, S. Fujii, H. Yamamoto, H. Kato, S. Takenaka, Y. Fuku, S. Hosogi, A. Hirono, K. Yamamoto, H. Tanaka, D. Hasegawa, Y. Nakamura, H. Tasaka, S. Otsuru, Y. Okamoto, C. Yamada, M. Miyamoto and K. Inoue Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis Am Heart J (2008) 155; 630-9 H. S. Gurm, T. Boyden and K. B. Welch Drug-eluting compared with bare-metal coronary stents among elderly patients J Am Coll Cardiol (2008) 51; 2017-24 P. W. Groeneveld, M. A. Matta, A. P. Greenhut and F. Yang Infrapopliteal drug-eluting stents for chronic limb ischemia Catheter Cardiovasc Interv (2008) 71; 108-11 A. G. Grant, C. J. White, T. J. Collins, J. S. Jenkins, J. P. Reilly and S. R. Ramee Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents J Am Coll Cardiol (2008) 52; 734-9 A. M. Gori, R. Marcucci, A. Migliorini, R. Valenti, G. Moschi, R. Paniccia, P. Buonamici, G. F. Gensini, R. Vergara, R. Abbate and D. Antoniucci Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry) Am J Cardiol (2008) 102; 1002-8 C. Godino, S. Furuichi, A. Latib, N. Morici, A. Chieffo, E. Romagnoli, C. Tamburino, R. Barbagallo, M. Cera, D. Antoniucci, O. Goktekin, C. Di Mario, B. Reimers, E. Grube, F. Airoldi, G. M. Sangiorgi and A. Colombo Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts Catheter Cardiovasc Interv (2008) 72; 13-20 . Gioia, A. Benassi, R. Mohendra, K. Chowdhury, I. Masood and W. Matthai Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study Catheter Cardiovasc Interv (2008) R. T. Gerber, A. Latib, A. Ielasi, J. Cosgrave, A. Qasim, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, J. Tobis and A. Colombo Measures of obesity and cardiovascular risk among men and women J Am Coll Cardiol (2008) 52; 605-15 R. P. Gelber, J. M. Gaziano, E. J. Orav, J. E. Manson, J. E. Buring and T. Kurth Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry Circulation (2008) 118; 2277-85, 7p following 85 P. Garg, S. L. Normand, T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, M. R. Varma, Z. Zhou and L. Mauri Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model J Am Coll Cardiol (2008) 51; 1844-53 P. Garg, D. J. Cohen, T. Gaziano and L. Mauri Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial A JAMA (2008) 299; 409-16 M. Galloe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. R. Hansen, N. Bligaard, K. Saunamaki, A. Junker, J. Aaroe, U. Abildgaard, J. Ravkilde, T. Engstrom, J. S. Jensen, H. R. Andersen, H. E. Botker, S. Galatius, S. D. Kristensen, J. K. Madsen, L. R. Krusell, S. Z. Abildstrom, G. B. Stephansen and J. F. Lassen Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings Eur Heart J (2008) 29; 1385 K. Fujii, M. Masutani and M. Ohyanagi Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents Catheter Cardiovasc Interv (2008) M. Freeman, D. J. Clark, N. Andrianopoulos, S. J. Duffy, H. S. Lim, A. Brennan, K. Charter, J. Shaw, M. Horrigan, A. E. Ajani, M. Sebastian, C. M. Reid and H. M. Farouque Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions Eur Heart J (2008) 29; 2859-67 M. Ferenc, M. Gick, R. P. Kienzle, H. P. Bestehorn, K. D. Werner, T. Comberg, P. Kuebler, H. J. Buttner and F. J. Neumann Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry Catheter Cardiovasc Interv (2008) 71; 629-35 . C. Fanggiday, P. R. Stella, S. H. Guyomi and P. A. Doevendans Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial Eur Heart J (2008) 29; 1625-34 S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin and G. W. Stone Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents Circulation (2009) 119; 1634-42 M. J. Eisenberg, P. R. Richard, D. Libersan and K. B. Filion Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial Catheter Cardiovasc Interv (2008) V. Dzavik, C. E. Buller, G. Devlin, R. G. Carere, G. B. Mancini, W. J. Cantor, P. E. Buszman, J. M. Rankin, C. Vozzi, J. R. Ross, S. Forman, B. A. Barton, A. G. Lamas and J. S. Hochman Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol (2008) 51; 986-90 J. M. de la Torre-Hernandez, F. Alfonso, F. Hernandez, J. Elizaga, M. Sanmartin, E. Pinar, I. Lozano, J. M. Vazquez, J. Botas, A. P. de Prado, J. M. Hernandez, J. Sanchis, J. M. Nodar, A. Gomez-Jaume, M. Larman, J. A. Diarte, J. Rodriguez-Collado, J. R. Rumoroso, J. R. Lopez-Minguez and J. Mauri NICE guidelines for the use of drug-eluting stents: how do we establish worth Heart (2008) 94; 1646-8 M. A. de Belder ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007 Eur Heart J (2009) 30; 152-61 J. Daemen, M. L. Simoons, W. Wijns, A. Bagust, G. Bos, J. M. Bowen, E. Braunwald, E. Camenzind, B. Chevalier, C. Dimario, J. Fajadet, A. Gitt, G. Guagliumi, H. L. Hillege, S. James, P. Juni, A. Kastrati, S. Kloth, S. D. Kristensen, M. Krucoff, V. Legrand, M. Pfisterer, M. Rothman, P. W. Serruys, S. Silber, P. G. Steg, I. Tariah, L. Wallentin, S. W. Windecker, A. Aimonetti, D. Allocco, A. Baczynska, M. Berenger, A. Boam, J. P. Calle, G. Campo, S. Carlier, J. de Schepper, G. Di Bisceglie, H. Dobbels, A. Farb, J. C. Ghislain, S. Hellbardt, R. Ten Hoedt, C. Isaia, P. de Jong, E. Klasen, M. Lekehal, L. Lenarz, F. Ni Mhullain, H. Nagai, A. Patteet, D. Paunovic, A. Potgieter, I. Purdy, C. Raveau-Landon, S. Ternstrom, J. Van Wuytswinkel and M. Waliszewski Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry Am J Cardiol (2008) 101; 1105-11 J. Daemen, N. Kukreja, P. H. van Twisk, Y. Onuma, P. P. de Jaegere, R. van Domburg and P. W. Serruys Drug-eluting stents vs. coronary-artery bypass grafting J. Daemen, N. Kukreja and P. W. Serruys J. Daemen, N. Kukreja and P. W. Serruys Late incomplete stent apposition after drug-eluting stent implantation: a true risk factor or "an innocent bystander"? Heart (2008) 94; 253-4 A. Colombo and A. Latib Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study Circulation (2009) 119; 71-8 A. Colombo, E. Bramucci, S. Sacca, R. Violini, C. Lettieri, R. Zanini, I. Sheiban, L. Paloscia, E. Grube, J. Schofer, L. Bolognese, M. Orlandi, G. Niccoli, A. Latib and F. Airoldi true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study Circulation (2009) 119; 71-8 A. Colombo, E. Bramucci, S. Sacca, R. Violini, C. Lettieri, R. Zanini, I. Sheiban, L. Paloscia, E. Grube, J. Schofer, L. Bolognese, M. Orlandi, G. Niccoli, A. Latib and F. Airoldi Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study Circulation (2008) 117; 2599-607 H. A. Chami, R. B. Devereux, J. S. Gottdiener, R. Mehra, M. J. Roman, E. J. Benjamin and D. J. Gottlieb Drug-eluting stents--pushing the envelope beyond the labels N Engel J Med (2008) 358; 405-7 J. P. Carrozza, Jr. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry Catheter Cardiovasc Interv (2009) 73; 310-6 D. Capodanno, M. E. Di Salvo, T. Palmerini, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, S. De Servi and C. Tamburino Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry Catheter Cardiovasc Interv (2009) 73; 457-65 F. Burzotta, C. Trani, D. Todaro, M. A. Mazzari, I. Porto, M. De Vita, S. Brugaletta, S. F. Coroleu, G. Niccoli, A. M. Leone, M. Giammarinaro, R. Mongiardo, G. Schiavoni and F. Crea Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study Eur Heart J (2008) 29; 3011-21 F. Burzotta, A. Parma, C. Pristipino, A. Manzoli, F. Belloni, G. Sardella, S. Rigattieri, A. Danesi, P. Mazzarotto, F. Summaria, E. Romagnoli, F. Prati, C. Trani and F. Crea Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2643; author reply 43-4 J. H. Burack Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group Catheter Cardiovasc Interv (2008) 72; 893-900 B. R. Brodie, T. Stuckey, W. Downey, A. Humphrey, M. Nussbaum, S. Laurent, B. Bradshaw, C. Metzger, J. Hermiller, F. Krainin, S. Juk, B. Cheek, P. Duffy and C. A. Simonton A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol (2009) 53; 919-28 E. S. Brilakis, C. Lichtenwalter, J. A. de Lemos, M. Roesle, O. Obel, D. Haagen, B. Saeed, C. Gadiparthi, J. K. Bissett, R. Sachdeva, V. V. Voudris, P. Karyofillis, B. Kar, J. Rossen, P. Fasseas, P. Berger and S. Banerjee Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol (2009) 103; 496-500 L. Bonello, A. De Labriolle, G. Lemesle, P. Roy, D. H. Steinberg, T. L. Slottow, Z. Xue, R. Torguson, K. Kaneshige, W. O. Suddath, L. F. Satler, K. M. Kent, J. Lindsay, A. D. Pichard and R. Waksman Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients Eur Heart J (2008) 29; 718-25 M. Billinger, J. Beutler, K. R. Taghetchian, A. Remondino, P. Wenaweser, S. Cook, M. Togni, C. Seiler, C. Stettler, F. R. Eberli, T. F. Luscher, S. Wandel, P. Juni, B. Meier and S. Windecker Inflation time and drug-eluting stent: the longer, the better Catheter Cardiovasc Interv (2009) 73; 212-3 O. F. Bertrand Outcomes in the era of bare-metal stents vs the era of drug-eluting stents JAMA (2009) 301; 33; author reply 34 A. Beri Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis Lancet (2008) 371; 2134-43 . A. Bavry and D. L. Bhatt Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents J Am Coll Cardiol (2008) 51; 970-1; author reply 71-2 D. Bansal, R. Sachdeva and J. L. Mehta Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents J Am Coll Cardiol (2008) 52; 789-90 M. Awata, S. Nanto, M. Uematsu, T. Morozumi, T. Watanabe, T. Onishi, O. Iida, F. Sera, J. Kotani, M. Hori and S. Nagata Bare-metal versus drug-eluting coronary stents N Engl J Med (2008) 358; 2516; author reply 17-8 D. Austin, J. P. Pell and K. G. Oldroyd Drug-eluting stents: do the risks really outweigh the benefits Heart (2008) 94; 127-8 D. Austin, J. P. Pell and K. G. Oldroyd Incidence of coronary stent thrombosis based on academic research consortium definitions Am J Cardiol (2008) 102; 683-8 R. J. Applegate, M. T. Sacrinty, W. C. Little, R. M. Santos, S. K. Gandhi and M. A. Kutcher "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents J Am Coll Cardiol (2008) 51; 607-14 R. J. Applegate, M. T. Sacrinty, M. A. Kutcher, R. M. Santos, S. K. Gandhi, T. T. Baki and W. C. Little Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis Catheter Cardiovasc Interv (2008) 72; 7-12 R. J. Applegate, M. Sacrinty, M. Kutcher, R. Santos, S. Gandhi and W. Little Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation (2009) 119; 687-98 J. Aoki, A. J. Lansky, R. Mehran, J. Moses, M. E. Bertrand, B. T. McLaurin, D. A. Cox, A. M. Lincoff, E. M. Ohman, H. D. White, H. Parise, M. B. Leon and G. W. Stone Treatment of drug-eluting stent restenosis: An emerging challenge Catheter Cardiovasc Interv (2008) A. Aminian, T. Kabir and E. Eeckhout Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies Catheter Cardiovasc Interv (2008) 72; 459-67 F. Alfonso, M. J. Perez-Vizcayno, R. Hernandez, C. Fernandez, J. Escaned, C. Banuelos, A. Bethencourt, J. R. Lopez-Minguez, J. Angel, A. Cequier, M. Sabate, C. Moris, J. Zueco and R. Seabra-Gomes Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study J Am Coll Cardiol (2008) 52; 1621-7 F. Alfonso, M. J. Perez-Vizcayno, R. Hernandez, A. Bethencourt, V. Marti, J. R. Lopez-Minguez, J. Angel, A. Iniguez, C. Moris, A. Cequier, M. Sabate, J. Escaned, P. Jimenez-Quevedo, C. Banuelos, A. Suarez and C. Macaya Bare-metal versus drug-eluting coronary stents N Engl J Med (2008) 358; 2516-7; author reply 17-8 P. Agostoni and P. Vermeersch Are surrogate end points in drug-eluting stent trials reliable? J Am Coll Cardiol (2008) 51; 1991-2; author reply 92 P. Agostoni and G. G. Biondi-Zoccai Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes Eur Heart J (2008) 29; 2868-76 T. Adriaenssens, R. A. Byrne, A. Dibra, R. Iijima, J. Mehilli, O. Bruskina, A. Schomig and A. Kastrati Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2642; author reply 43-4 A. Abbate and M. J. Lipinski